Delos Santos, Marcelin A.

HRN: 04-33-22  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2022
CEFUROXIME 1.5GM (VIAL)
07/23/2022
07/23/2022
IV
1.5g
LD
Preop Prophylaxis
Waiting Final Action 
07/23/2022
CEFUROXIME 750MG (VIAL)
07/23/2022
07/30/2022
IVT
750mg
Q8
S/P CS With BTL
07/24/2022
CEFUROXIME 500MG (TAB)
07/24/2022
07/31/2022
PO
500mg
Q12
Post Op Prophylaxis
Waiting Final Action 
07/24/2022
METRONIDAZOLE 500MG (TAB)
07/24/2022
07/31/2022
PO
500mg
Q8
Post CS; Thickly MSAF
Waiting Final Action 
07/28/2022
CEFUROXIME 500MG (TAB)
07/28/2022
07/31/2022
ORAL
500mg
BID
S/P CS
Waiting Final Action 
07/28/2022
METRONIDAZOLE 500MG (TAB)
07/28/2022
07/31/2022
ORAL
500mg
TID
S/P CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: